[go: up one dir, main page]

ES8606408A1 - Un procedimiento para preparar octapeptidos antagonistas de vasopresina - Google Patents

Un procedimiento para preparar octapeptidos antagonistas de vasopresina

Info

Publication number
ES8606408A1
ES8606408A1 ES529738A ES529738A ES8606408A1 ES 8606408 A1 ES8606408 A1 ES 8606408A1 ES 529738 A ES529738 A ES 529738A ES 529738 A ES529738 A ES 529738A ES 8606408 A1 ES8606408 A1 ES 8606408A1
Authority
ES
Spain
Prior art keywords
phe
val
arg
pro
octapeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES529738A
Other languages
English (en)
Other versions
ES529738A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of ES529738A0 publication Critical patent/ES529738A0/es
Publication of ES8606408A1 publication Critical patent/ES8606408A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR OCTAPEPTIDOS ANTAGONISTAS DE VASOPRESINA. COMPRENDE: A) CICLISAR UN COMPUESTO DE FORMULA (II) POR OXIDACION EN PRESENCIA DE YODO O FERRICIANURO; B) SEPARAR LOS GRUPOS PROTECTORES MEDIANTE SALES DE ACETATO (HALO) MERCURICO EN METANOL ACUOSO A UNA TEMPERATURA ENTRE 0 Y 80JC, PARA OBTENER UN COMPUESTO DE FORMULA (I) O UN PROFARMACO O SAL DE DICHOS COMPUESTOS. SIENDO: A VAL, ILE Y OTROS; CAP ES UN ACIDO B, B-CICLOALQUILEN-PROPIONICO CON S-Q1 FIJADO EN LA POSICION B Y CON 5 A 7 UNIDADES EN LA CADENA DE CICLOALQUILENO; P ES PHE O PHE (4K-ALQ); Q1 Y Q2 SON H O UN GRUPO DESPLAZABLE; W ES D-PRO, L-PRO Y OTROS; X ES D-PHE, D-VAL, Y OTROS; Y ES NH2, NHALA, Y OTROS; Z ES D-ARG, L-ARG, Y OTROS. SE UTILIZA COMO DIURETICO DE AGUA.
ES529738A 1983-02-16 1984-02-15 Un procedimiento para preparar octapeptidos antagonistas de vasopresina Expired ES8606408A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/467,117 US4469679A (en) 1983-02-16 1983-02-16 Octapeptide vasopressin antagonists

Publications (2)

Publication Number Publication Date
ES529738A0 ES529738A0 (es) 1986-04-01
ES8606408A1 true ES8606408A1 (es) 1986-04-01

Family

ID=23854436

Family Applications (2)

Application Number Title Priority Date Filing Date
ES529738A Expired ES8606408A1 (es) 1983-02-16 1984-02-15 Un procedimiento para preparar octapeptidos antagonistas de vasopresina
ES535842A Granted ES535842A0 (es) 1983-02-16 1984-09-12 Un procedimiento para preparar octapeptidos lineales

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES535842A Granted ES535842A0 (es) 1983-02-16 1984-09-12 Un procedimiento para preparar octapeptidos lineales

Country Status (20)

Country Link
US (2) US4469679A (es)
EP (1) EP0119705B1 (es)
JP (1) JPS59155348A (es)
KR (1) KR850001230A (es)
AT (1) ATE46174T1 (es)
AU (1) AU577778B2 (es)
DE (1) DE3479664D1 (es)
DK (1) DK65284A (es)
ES (2) ES8606408A1 (es)
FI (1) FI840577L (es)
GR (1) GR81786B (es)
HU (1) HU196227B (es)
IE (1) IE56859B1 (es)
IL (1) IL70944A (es)
NO (1) NO840563L (es)
NZ (1) NZ207106A (es)
PH (1) PH20076A (es)
PT (1) PT78094B (es)
ZA (1) ZA841104B (es)
ZW (1) ZW1884A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2708547A (en) * 1950-07-19 1955-05-17 Semt Exhaust gas turbo-blowers for high supercharging rates and method of mounting same
US4649130A (en) * 1984-01-26 1987-03-10 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
US4714696A (en) * 1984-01-26 1987-12-22 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
US4599324A (en) * 1984-11-21 1986-07-08 Smithkline Beckman Corporation V1-vasopressin antagonists
US4684716A (en) * 1984-12-14 1987-08-04 Smithkline Beckman Corporation Polypeptide intermediates
US4624943A (en) * 1985-03-20 1986-11-25 Smithkline Beckman Corporation Aromatic basic-tailed vasopressin antagonists
US4656248A (en) * 1985-04-23 1987-04-07 Smithkline Beckman Corporation Cupric oxidation of 1,6-dimercapto-containing peptides
US4711877A (en) * 1985-09-18 1987-12-08 Smithkline Beckman Corporation 6-pen-vasopressin compounds
US4742154A (en) * 1985-10-23 1988-05-03 Smithkline Beckman Corporation GLN- or ASN-vasopressin compounds
US4687758A (en) * 1985-11-19 1987-08-18 Smithkline Beckman Corporation Des-proline-N-methylarginine vasopressins
US4760052A (en) * 1986-01-16 1988-07-26 Smithkline Beckman Corporation 1,6-dicarba-vasopressin compounds
US4876243A (en) * 1986-02-25 1989-10-24 Smithkline Beckman Corporation Vasopressin compounds
US4717715A (en) * 1986-06-23 1988-01-05 Smithkline Beckman Corporation ARG7 -ARG8 -vasopressin antagonists
US4724229A (en) * 1986-09-30 1988-02-09 Smithkline Beckman Corporation Arg-arg-arg-vasopressin antagonists
US4766108A (en) * 1986-12-04 1988-08-23 Smith Kline Beckman Corporation Tyr-Arg-vasopressin antagonists
US4826813A (en) * 1987-05-21 1989-05-02 Smithkline Beckman Corporation 4'-Methyl-β-mercapto-β,β-cyclopentamethylenepropionic acid vasopressin antagonists
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
JP2542241B2 (ja) * 1988-08-12 1996-10-09 富士レビオ株式会社 ペプチド
US5051400A (en) * 1990-06-28 1991-09-24 Smithkline Beecham Corporation Method of treating nausea and emesis related to motion sickness with vasopressin antagonists
US6759384B1 (en) 1994-04-26 2004-07-06 Aventis Pharmaceuticals Inc. Factor Xa inhibitors
US5849510A (en) * 1994-04-26 1998-12-15 Selectide Corporation Factor Xa inhibitors
EP1384725A3 (en) * 1994-04-26 2007-02-21 Aventis Pharmaceuticals Inc. Factor Xa inhibitors
US6001809A (en) * 1994-07-11 1999-12-14 Elan Pharmaceuticals, Inc. Inhibitors of leukocyte adhesion
CA2321026A1 (en) * 1998-03-09 1999-09-16 Zealand Pharmaceuticals A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1246055A (en) * 1980-03-24 1988-12-06 Joseph H. Cort N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs
US4399125A (en) * 1981-03-24 1983-08-16 Maurice Manning Novel antagonists of the antidiuretic action of arginine vasopressin
US4367225A (en) * 1981-03-24 1983-01-04 The Medical College Of Ohio Novel antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin
US4643520A (en) * 1983-03-10 1987-02-17 Allied Corporation Method of terminating fiber optic connector without polishing optical fiber

Also Published As

Publication number Publication date
FI840577A7 (fi) 1984-08-17
US4542124A (en) 1985-09-17
EP0119705A2 (en) 1984-09-26
IL70944A0 (en) 1984-05-31
FI840577A0 (fi) 1984-02-14
NZ207106A (en) 1990-12-21
EP0119705A3 (en) 1987-04-22
IL70944A (en) 1990-11-29
IE840352L (en) 1984-08-16
FI840577L (fi) 1984-08-17
PT78094B (en) 1986-05-20
ES529738A0 (es) 1986-04-01
EP0119705B1 (en) 1989-09-06
DK65284A (da) 1984-08-17
ES8600216A1 (es) 1985-10-01
US4469679A (en) 1984-09-04
HUT34042A (en) 1985-01-28
HU196227B (en) 1988-10-28
AU2453484A (en) 1984-08-23
ATE46174T1 (de) 1989-09-15
ES535842A0 (es) 1985-10-01
GR81786B (es) 1984-12-12
DE3479664D1 (en) 1989-10-12
AU577778B2 (en) 1988-10-06
KR850001230A (ko) 1985-03-16
DK65284D0 (da) 1984-02-14
ZA841104B (en) 1985-04-24
PH20076A (en) 1986-09-18
ZW1884A1 (en) 1984-05-30
NO840563L (no) 1984-08-17
JPS59155348A (ja) 1984-09-04
IE56859B1 (en) 1992-01-01
PT78094A (en) 1984-03-01

Similar Documents

Publication Publication Date Title
ES8606408A1 (es) Un procedimiento para preparar octapeptidos antagonistas de vasopresina
ES8800170A1 (es) Un procedimiento para la preparacion de pirazolo- y piridazo-pirazolinas, -piridazinas y -diacepinas
LV5795B4 (lv) LHL antagonisti
JPS565448A (en) Organic compound
SE7413710L (es)
NO933455D0 (no) Bis-naftalimider som inneholder aminosyreavledete linkere, for anvendelse som antikreftmidler
ES345047A1 (es) Procedimiento para la preparacion de un polipeptido activo como antidiuretico.
ATE63750T1 (de) Peptid, dessen herstellung und benutzung.
TR200100273T2 (tr) Enjeksiyon için parasetamol bazlı farmasötik bileşim.
ES2133295T3 (es) Peptidos ciclicos y su uso.
KR850006941A (ko) 데스-프로린 바조프레신 길항제의 제조방법
AR241800A1 (es) Procedimiento para preparar compuestos de eglina y procedimiento para obtener preparados farmaceuticos que incluyan a dichos compuestos de eglina como agente activo.
DE3775156D1 (de) Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und und ihre verwendung.
KR850002834A (ko) 염기성 헵타 펩타이드 바조프레신 길항근의 제조방법
IT1213287B (it) Peptidi comprendenti la sequenza diaamminoacidi del peptide derivante dal gene della calcitonina,loro sali e complessi farmaceuticamente accettabili e composizioni farmaceutiche che li contengono
ES8707550A1 (es) Un procedimiento para preparar compuestos peptidicos sustituidos.
EP0225746A3 (en) Therapeutic decapeptides
NO932769D0 (no) Faktor iia inhibitorer
ES8608478A1 (es) Un metodo de preparar bestatinas
GB1059854A (en) Improvements in or relating to a cyclic nonapeptide
ATE59393T1 (de) Peptide.
GB1067935A (en) Improvements in or relating to nonapeptide derivatives
ES417951A1 (es) Un procedimiento para la preparacion de nuevos peptidos de actividades acth.
KR890005149A (ko) 합성 펩타이드 및 이를 포함한 제약학적 조성물
GB1451389A (en) Indolobenzazepines

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203